Received Feb 22, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
administration on 23-Dec-2025 of only the liquid portion of the Menveo 2 vial presentation to a patient.; Inappropriate dose of vaccine administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. On 23-DEC-2025, the patient received Menveo. On 23-DEC-2025, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: administration on 23-Dec-2025 of only the liquid portion of the Menveo 2 vial presentation to a patient.) and inappropriate dose of vaccine administered (Verbatim: Inappropriate dose of vaccine administered). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK receipt date: 17-FEB-2026 The batch number was not provided upon follow up with the reporter.